IN VIVO RNAI SCREENS TO IDENTIFY NOVEL T CELL-DEPENDENT IMMUNOTHERAPEUTIC TARGETS OF BREAST CANCER

$699,141FY2016Department of the ArmyDOD

Scripps Research Institute, The, La Jolla CA

Investigators